Cardio Diagnostics Holdings Stock Analysis

Cardio Stock Analysis Notes

The company had not issued any dividends in recent years. Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. For more info on Cardio Diagnostics Holdings please contact Meeshanthini Dogan at 855 226 9991 or go to https://cdio.ai.

Cardio Diagnostics Investment Alerts

Cardio Profitablity

Management Efficiency

The company has return on total asset (ROA) of (0.6158) % which means that it has lost $0.6158 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.107) %, meaning that it generated substantial loss on money invested by shareholders. Cardio Diagnostics' management efficiency ratios could be used to measure how well Cardio Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.8 in 2026. Return On Capital Employed is likely to drop to -0.79 in 2026. At this time, Cardio Diagnostics' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 2.2 M in 2026, whereas Intangible Assets are likely to drop slightly above 462.2 K in 2026.

Technical Drivers

As of the 10th of February, Cardio Diagnostics shows the Downside Deviation of 8.53, risk adjusted performance of 0.0264, and Mean Deviation of 5.9. Cardio Diagnostics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cardio Diagnostics standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Cardio Diagnostics is priced correctly, providing market reflects its regular price of 0.0174 per share. As Cardio Diagnostics appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Cardio Diagnostics Price Movement Analysis

Cardio Diagnostics Insider Trading Activities

Cardio Diagnostics Outstanding Bonds

Cardio Diagnostics Predictive Daily Indicators

Cardio Diagnostics Forecast Models

Cardio Diagnostics' time-series forecasting models are one of many Cardio Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cardio Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Cardio Diagnostics Bond Ratings

Cardio Diagnostics Holdings financial ratings play a critical role in determining how much Cardio Diagnostics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Cardio Diagnostics' borrowing costs.

Cardio Diagnostics Total Assets Over Time

Cardio Diagnostics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Cardio Diagnostics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Cardio Diagnostics Debt Ratio

19.0

It appears most of the Cardio Diagnostics' assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Cardio Diagnostics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Cardio Diagnostics, which in turn will lower the firm's financial flexibility.

Cardio Diagnostics Corporate Bonds Issued

Cardio Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardio Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cardio Diagnostics. By using and applying Cardio Stock analysis, traders can create a robust methodology for identifying Cardio entry and exit points for their positions.

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.